AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

Clinical trial NCT06611423 · TERMINATED

Trial details

NCT number: NCT06611423
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction (HFrEF)Renal Impairment

Start date: 2024-10-15
Primary completion: 2025-08-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.